Will Cassava Sciences Stock Continue To See Lower Levels?

Will Cassava Sciences Stock Continue To See Lower Levels?

The stock price of Cassava Sciences plunged 23% yesterday after a report that the U.S. SEC is investigating the company over allegations of data manipulation for its experimental Alzheimer’s treatment – Simufilam. [1] SAVA stock saw a large fall in September following a citizen petition filed to…